EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY

Scope & Guideline

Fostering Knowledge for Better Patient Outcomes

Introduction

Immerse yourself in the scholarly insights of EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN0392-2936
PublisherMRE PRESS
Support Open AccessNo
Country-
TypeJournal
Convergefrom 1980 to 2021 (coverage discontinued in Scopus)
AbbreviationEUR J GYNAECOL ONCOL / Eur. J. Gynaecol. Oncol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address14 ROBINSON RD #08-01A FAR EAST FINANCE, SINGAPORE 048545, SINGAPORE

Aims and Scopes

The European Journal of Gynaecological Oncology focuses on advancing knowledge and practice in the field of gynecological cancers through rigorous research and clinical studies. The journal aims to provide a platform for the dissemination of significant findings that can improve patient outcomes and inform treatment strategies.
  1. Gynecological Cancer Research:
    The journal emphasizes original research on various gynecological cancers, including endometrial, ovarian, cervical, and vulvar cancers, with a focus on novel therapeutic approaches and clinical outcomes.
  2. Clinical Trials and Interventions:
    A significant portion of the journal's content includes clinical trials and intervention studies aimed at evaluating the efficacy and safety of new treatment protocols, surgical techniques, and adjuvant therapies.
  3. Biomarkers and Diagnostic Tools:
    Research on biomarkers for early detection, prognosis, and treatment response in gynecological cancers is a core area, highlighting the importance of personalized medicine in oncology.
  4. Surgical Techniques and Innovations:
    The journal publishes studies on innovative surgical techniques, including minimally invasive and robotic surgeries, aimed at improving surgical outcomes and patient recovery.
  5. Patient Quality of Life and Psychosocial Factors:
    The impact of cancer treatment on patients' quality of life, including psychosocial factors, is a recurring theme, emphasizing holistic approaches to cancer care.
  6. Epidemiological Studies:
    Epidemiological research that examines trends, risk factors, and outcomes related to gynecological cancers is also a significant focus area.
The European Journal of Gynaecological Oncology has adapted to the evolving landscape of cancer research, with emerging themes reflecting current trends and innovations in the field. This section highlights these trending topics.
  1. Precision Medicine and Genomics:
    There is a growing emphasis on precision medicine, including genomic studies and biomarker research, which is increasingly informing treatment decisions and personalized therapies in gynecological oncology.
  2. Artificial Intelligence and Digital Health:
    Emerging themes include the use of artificial intelligence and machine learning in cancer diagnostics and treatment planning, showcasing the integration of technology in clinical practice.
  3. Multidisciplinary Approaches to Care:
    The journal is increasingly publishing articles that emphasize multidisciplinary care models, integrating various specialties to enhance treatment efficacy and patient outcomes.
  4. Quality of Life and Supportive Care:
    Research focusing on quality of life, survivorship, and supportive care interventions is becoming more prevalent, reflecting an understanding of the importance of holistic care in cancer treatment.
  5. Innovative Surgical Techniques:
    There is a trend towards exploring new surgical techniques, particularly robotic and minimally invasive surgeries, which aim to reduce recovery times and improve patient safety.

Declining or Waning

While the journal has consistently focused on several core areas, certain themes appear to be declining in prominence based on recent publications. This section outlines those waning topics.
  1. Traditional Cancer Treatments:
    There has been a noticeable decrease in publications focusing on conventional treatment modalities without innovative approaches, such as standard chemotherapy and radiation, as more research shifts towards personalized and targeted therapies.
  2. Basic Science and Preclinical Studies:
    The journal has seen a decline in basic science studies and preclinical research, as the focus increasingly shifts towards clinical applications and patient-centered outcomes.
  3. Single-Cancer Focus Studies:
    Research focusing solely on one type of gynecological cancer without comparative studies or integrated approaches has become less common, as interdisciplinary research and holistic perspectives gain traction.
  4. Outdated Surgical Techniques:
    Older surgical methods that lack innovative enhancements or technological integration are featured less frequently, reflecting a trend towards modern and minimally invasive surgical interventions.

Similar Journals

Clinical Genitourinary Cancer

Inspiring the future of genitourinary cancer care.
Publisher: CIG MEDIA GROUP, LPISSN: 1558-7673Frequency: 6 issues/year

Clinical Genitourinary Cancer, published by CIG MEDIA GROUP, LP, is a leading journal in the fields of Oncology and Urology, with an impressive impact reflected in its quartile rankings (Q2 in Oncology and Q1 in Urology for 2023) and strong Scopus rankings (22nd in Urology and 162nd in Oncology). The journal aims to innovate and inspire new research in genitourinary malignancies, providing a platform for the latest findings in diagnosis, treatment, and patient management. With its commitment to high-quality publications since its establishment in 2005, Clinical Genitourinary Cancer serves a crucial role in advancing the understanding of these complex conditions and enhancing clinical practices. Researchers, professionals, and students in the medical community are encouraged to engage with this essential resource, which facilitates open access to pioneering studies that drive the field forward.

Journal of the Turkish-German Gynecological Association

Empowering Healthcare Professionals with Cutting-Edge Insights
Publisher: GALENOS PUBL HOUSEISSN: 1309-0399Frequency: 4 issues/year

The Journal of the Turkish-German Gynecological Association, published by GALENOS PUBL HOUSE, stands as a significant contribution to the field of obstetrics and gynecology, fostering a vital dialogue between Turkish and German medical communities since its establishment. This peer-reviewed, Open Access journal, which has been accessible since 2000, provides a platform for the dissemination of cutting-edge research, clinical practices, and reviews that are pivotal for advancing women's health. With a current impact factor correlation reflecting its status within the Q3 category in the obstetrics and gynecology domain, the journal is ranked #108 out of 209 in Scopus, placing it in the 48th percentile for its field. Covering a broad range of topics from innovative treatment methods to emerging technologies in gynecology, this journal is dedicated to enriching the academic landscape and providing healthcare professionals, researchers, and students with valuable insights and knowledge essential for improving patient outcomes. The journal’s headquarters in Turkey underscores its commitment to enriching local and international discourse in women's health.

Southern African Journal of Gynaecological Oncology

Advancing women's health through groundbreaking research.
Publisher: MEDPHARM PUBLICATIONS PTY LTDISSN: 2074-2835Frequency: 2 issues/year

The Southern African Journal of Gynaecological Oncology, published by MEDPHARM PUBLICATIONS PTY LTD, is a leading open-access journal that has been at the forefront of disseminating critical research in the field of gynecological oncology since its inception in 2009. With an ISSN of 2074-2835 and an E-ISSN of 2220-105X, this journal serves as a vital resource for researchers, healthcare professionals, and students interested in the nuanced complexities of women's health, particularly in the context of Southern Africa. The journal is dedicated to promoting innovative findings and clinical practices to enhance patient care in gynecological cancer treatment and prevention. Its open-access model ensures that high-quality, peer-reviewed research is readily available to a global audience, fostering collaboration and knowledge sharing within the academic community. As the journal continues to grow, it emphasizes the importance of addressing regional health challenges and advancing the discourse in gynecological oncology.

Oncology Research and Treatment

Empowering the future of oncology with cutting-edge insights.
Publisher: KARGERISSN: 2296-5270Frequency: 10 issues/year

Oncology Research and Treatment, published by KARGER, is a highly regarded academic journal dedicated to advancing the field of oncology through rigorous research and clinical insights. With a history spanning from 1978 to 1997 and continuing from 2013 to 2024, this journal provides a vital platform for researchers and professionals in cancer research, hematology, and related disciplines. Though currently listed in the Q3 tier of 2023 for Cancer Research, Hematology, and Oncology, its growing readership and open access policy enhance its visibility and impact within the scientific community. Based in Switzerland, the journal features diverse access options, reflecting the global importance of oncology research. With a focus on innovative treatments and the latest methodologies, Oncology Research and Treatment plays a crucial role in fostering collaboration and dialogue among researchers, professionals, and students alike, helping to shape the future of cancer care and management.

SURGICAL ONCOLOGY-OXFORD

Innovating oncology surgery through comprehensive peer-reviewed studies.
Publisher: ELSEVIER SCI LTDISSN: 0960-7404Frequency: 4 issues/year

Surgical Oncology-Oxford is a prestigious academic journal published by Elsevier Science Ltd, dedicated to advancing the field of surgical oncology. Since its establishment in 1992, the journal has provided a vital platform for disseminating cutting-edge research, clinical advancements, and innovative surgical techniques. With a focus on both surgery and oncology, the journal is ranked in the Q2 category in Surgery and Q3 in Oncology for 2023, reflecting its commitment to quality and impactful contributions. It ranks #107 out of 551 in Medicine_Surgery and #184 out of 404 in Medicine_Oncology as per Scopus metrics, illustrating its significant role in the academic landscape. Although it does not currently offer open access options, the journal's rigorous peer-review process ensures that only the highest quality research is published. By examining the latest surgical methodologies and oncological insights, Surgical Oncology-Oxford plays a crucial role in enhancing clinical practice and improving patient outcomes, making it an essential resource for researchers, healthcare professionals, and students aiming to stay at the forefront of the field.

Bladder Cancer

Elevating the standard of care through impactful research.
Publisher: IOS PRESSISSN: 2352-3727Frequency: 4 issues/year

Bladder Cancer, published by IOS PRESS, is a premier open access journal dedicated to advancing the field of oncology and urology, with a specific focus on bladder cancer research and treatment. Established in 2015 and continuing through to 2024, this journal aims to disseminate high-quality, peer-reviewed research that contributes to the understanding, diagnosis, and management of bladder cancer, a critical area of concern in urological oncology. With a robust publication record now encompassing open access since 2023, Bladder Cancer ensures accessibility to vital research for clinicians, researchers, and scholars worldwide. The journal's rankings in Scopus reflect its commitment to excellence, holding a Q3 category in both oncology and urology, with Scopus ranks of #78 in Urology and #285 in Oncology, showcasing its growing influence in the scientific community. By fostering dialogue and innovation, Bladder Cancer serves as an essential resource for those committed to improving patient outcomes in bladder oncology.

Cancer Management and Research

Pioneering new paths in cancer management and research.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-1322Frequency: 1 issue/year

Cancer Management and Research, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to advancing the field of oncology. Since its inception in 2009, this journal has established itself as a vital resource for researchers, clinicians, and healthcare professionals focused on cancer treatment and management. With its robust impact factor and impressive Scopus ranking in the 77th percentile of oncology medicine, it provides a prominent platform for sharing high-quality research. The journal covers a wide range of topics within cancer management, including innovative therapeutic strategies, clinical trials, patient care, and health policy, ensuring a comprehensive approach to current challenges in the field. Operating from New Zealand, it invites contributions that can shape the future of oncology and improve patient outcomes globally, making it an essential addition to the libraries of those engaged in cancer research and practice.

Indian Journal of Surgical Oncology

Transforming Surgical Oncology through Collaborative Discourse
Publisher: SPRINGER INDIAISSN: 0975-7651Frequency: 4 issues/year

The Indian Journal of Surgical Oncology, published by SPRINGER INDIA, is a vital source of scholarly research and discourse in the fields of oncology and surgery. Since its inception in 2010, the journal has been dedicated to advancing the science and practice of surgical oncology, providing a platform for researchers, clinicians, and educators to disseminate their findings and insights. With an increasing impact factor, the journal currently ranks in the Q4 category in Oncology and Q3 category in Surgery, reflecting its growing influence in the academic community. The journal maintains a focus on high-quality research, clinical studies, and innovative surgical techniques, fostering knowledge exchange among professionals in India and beyond. Although an open access option is not provided, the journal remains an essential repository of information for anyone engaged in the rapidly evolving fields of surgical oncology. For access to groundbreaking research and updates in the discipline, the Indian Journal of Surgical Oncology continues to be an indispensable resource.

Journal of Gastrointestinal Cancer

Driving innovation in gastrointestinal cancer research.
Publisher: SPRINGERISSN: 1941-6628Frequency: 4 issues/year

Journal of Gastrointestinal Cancer, published by SPRINGER, stands as a crucial resource in the fields of Gastroenterology and Oncology. With an ISSN of 1941-6628 and E-ISSN of 1941-6636, this journal has been committed to advancing the understanding and treatment of gastrointestinal cancers since its inception in 2007 and is poised to continue until 2024. The journal is recognized in the Q3 quartiles for both Gastroenterology and Oncology as of 2023, reflecting its relevance and contribution to these vital areas of medical research. Despite not being an open-access journal, it offers printed and online subscription options for access, ensuring that valuable research reaches the hands of practitioners, researchers, and students alike. With a focus on disseminating original research, reviews, and case studies, the Journal of Gastrointestinal Cancer plays a pivotal role in fostering ongoing education and discovery in the fight against cancer, promoting better patient outcomes worldwide. The journal is also indexed in Scopus, with notable rankings in the 50th and 45th percentiles for Gastroenterology and Oncology, respectively, further underscoring its scientific merit and credibility in the academic community.

Ceska Gynekologie-Czech Gynaecology

Connecting Research and Practice for Better Outcomes
Publisher: NAKLADATELSKE STREDISKO C L S J E PURKYNEISSN: 1210-7832Frequency: 6 issues/year

Ceska Gynekologie-Czech Gynaecology, ISSN 1210-7832, is a prominent journal in the field of obstetrics and gynecology, published by the esteemed NAKLADATELSKE STREDISKO C L S J E PURKYNE in the Czech Republic. Since its inception in 1959, this journal has served as a vital resource for researchers, practitioners, and students by disseminating high-quality research and insights pertinent to women's health. The journal is currently ranked in the Q3 category for Obstetrics and Gynecology, reflecting its respected position within the academic community, despite its Scopus ranking of #161 out of 209 in the medical field. Ceska Gynekologie offers a platform for sharing innovative clinical practices, research advancements, and educational resources, contributing significantly to the advancement of gynecological care. With a commitment to fostering professional knowledge and practice, this journal remains an essential tool for those engaged in the intricate world of women's health.